# Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma

> **NCT02567539** · NA · COMPLETED · sponsor: **Istituto Clinico Humanitas** · enrollment: 88 (actual)

## Conditions studied

- Recurrent High Grade Glioma

## Interventions

- **RADIATION:** IMRT with or without radiosensitive therapy
- **DRUG:** Radiosensitive therapy

## Key facts

- **NCT ID:** NCT02567539
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-27
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2022-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02567539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02567539, "Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT02567539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*